Alexandria For Pharmaceuticals & Chemical Industries Balance Sheet Health
Financial Health criteria checks 4/6
Alexandria For Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP719.3M and total debt of EGP6.1M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are EGP183.9M and EGP-535.4M respectively. Alexandria For Pharmaceuticals & Chemical Industries's EBIT is EGP184.6M making its interest coverage ratio -32. It has cash and short-term investments of EGP135.5M.
Debt to equity ratio
|Interest coverage ratio
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: AXPH's short term assets (EGP736.9M) exceed its short term liabilities (EGP350.1M).
Long Term Liabilities: AXPH's short term assets (EGP736.9M) do not cover its long term liabilities (EGP-885.6M).
Debt to Equity History and Analysis
Debt Level: AXPH has more cash than its total debt.
Reducing Debt: AXPH's debt to equity ratio has increased from 0.2% to 0.9% over the past 5 years.
Debt Coverage: AXPH's debt is well covered by operating cash flow (2643%).
Interest Coverage: AXPH earns more interest than it pays, so coverage of interest payments is not a concern.